Disability Evaluation Physician (ENT) – MD/DO | Part-Time (2–3 Days/Month)
The IMA Group is seeking a Board-Certified or Board-Eligible ENT Physician for flexible, supplemental work performing disability evaluations — no treatment, no prescribing, no ongoing patient care.
What You'll Do
What You'll Need
Why Physicians Choose IMA
Ideal for ENT physicians looking to supplement their income with predictable, evaluation-only work — no clinical treatment setting required.
The IMA Group is an Affirmative Action/Equal Opportunity Employer
Our Government Services Division supports local, state, and federal agencies and delivers professional and objective medical and psychological examinations as well as ancillary services. Our Payer Services Division meets the evaluation and screening needs of Carriers, TPAs, Public Entities and Employers and includes behavioral health and physical medicine specialty services, working with a wide range of organizations within the workers' compensation, disability, liability, and auto markets. Our Clinical Research Division performs all types of Phase II-IV clinical trials in multiple therapeutic areas through a flexible nationwide network of site locations and virtual capabilities.
#LI-TM1 #LI-ONSITE
For over 30 years, The IMA Group has been dedicated to enhancing the livelihood and productivity of individuals and organizations navigating challenging periods of health, work and disability while actively contributing to the development of new medical treatments and clinical advancements. With thousands of licensed providers and over 150 offices nationwide, IMA is able to serve national needs while maintaining a regional focus.
IMA has two divisions: Evaluation Services including Government and Payer and a Clinical Research Site Network. We provide medical and psychological evaluations and other ancillary services to federal, state, and local governments and agencies, commercial insurers, TPAs and corporate clients. Our Clinical Research Division specializes in Phase II, III, and IV clinical trials in multiple therapeutic areas through our nationwide multi-site network.
